Researchers have also not seen any new cases of vaccine-induced immune thrombocytopenia (Vitt) in the last three to four weeks, suggesting that the decision to offer an alternative COVID19 vaccine to under-40s may have played a role
offered an alternative vaccineResearchers evaluated 294 patients, aged between 18 and 79, 220 of whom were classed as either definite or probable cases of Vitt.
Treatments include a plasma exchange - where plasma is taken from the blood and replaced with new fluid - steroids to dampen the immune system, administering immunoglobulins to increase platelet count and blood thinners to prevent future clots. There were 73 deaths, the MHRA said. At the time, an estimated 24.8 million first doses of the jab had been administered, and 23.6 million second doses.